Skip to main content
OpenTrials
Completed

NCT Number: NCT00838292

Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya

The purpose of the study is to test whether food supplementation of malnourished HIV-infected adults (both pre-ART and ART) in resource constrained settings improves their nutritional status, clinical status, effectiveness of treatment, quality of life, functioning, and survival.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Maragwa District Hospital, Maragwa, Kenya

Loading trial locations.

About this study

Malnutrition remains a significant problem among HIV-infected populations, even among those with access to ART. In patients with HIV infection, poor nutritional status is associated with significant reduction in survival rates, accelerated disease progression, diminished response to therapies including ART, increased susceptibility to opportunistic infections, and reduced work capacity and quality of life. However, there is not evidence whether delay or reversal of weight loss improves life expectancy, nor is there evidence about the specific benefits food supplementation has on people with HIV infection. As antiretroviral therapy (ART) services continue to scale up in sub-Saharan Africa, there is a critical need for information about the impacts of appropriate food supplementation on the effectiveness of ART, on the health status of clients, and on the progression of the disease.

Malnourished adult ART and pre-ART clients at six clinical sites in Kenya are randomly allocated either to a group that receives nutrition counseling only or a group that receives nutrition counseling and supplementary feeding for six months. All patients continue to receive medical treatment (ART and other medicine) according to their condition. Baseline measures of socioeconomic and demographic status are collected. Measures of both nutritional and non-nutritional clinical outcomes are collected at baseline, 3, 6, 9, and 12 months. Clients beginning ART are treated as one arm and randomized between food and non-food, and clients not yet eligible for ART (pre-ART) are treated as a second arm and randomized between food and non-food. Within each arm, outcomes of subjects receiving supplemental food will be compared with outcomes of those who are not.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HIV-infected
  • BMI < 18.5
  • Resident of area for past 6 months

Exclusion criteria

  • Pregnant or lactating (child < 6 months)
  • BMI > 18.5, BMI < 14
  • Already receiving other food supplements

Treatment and study plan

fortified blended flour - Insta Foundation Plus (with whey protein concentrate)

Dietary Supplement

300 grams/day for 6 months

Other names: Insta Products Ltd. Foundation Plus product with whey protein concentrate.

Nutrition Counseling

Other

Primary outcomes

  1. Body Mass Index

    Time frame: monthly

Secondary outcomes

  1. CD4 counts

    Time frame: every three months (quarterly)

  2. Quality of Life

    Time frame: monthly

  3. drug adherence

    Time frame: monthly

Sponsors and collaborators

Lead sponsor

Academy for Educational Development

Industry

Collaborators

  • Kenya Medical Research Institute

Registry information

Official study title

Randomized Controlled Evaluation of the Impact of Food Supplements on Malnourished HIV-Infected Adult ART Clients and Malnourished, HIV-Infected Pre-ART Adults in Kenya

Important dates

Study start
2006
Primary completion
2008
Study completion
2008
First posted
Feb 6, 2009
Registry last updated
Mar 13, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.